$200m spac led by healthcare technology industry experts focused on disruptive health-tech companies that leverage data science to improve and personalize healthcare.
Company profile
Ticker
FHLT, FHLTU, FHLTW
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
862305680
FHLT stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
21 Sep 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8 Aug 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5 Jun 23
10-Q
2023 Q1
Quarterly report
8 May 23
8-K
Entry into a Material Definitive Agreement
28 Mar 23
8-K
Other Events
9 Mar 23
10-K
2022 FY
Annual report
8 Mar 23
8-K
Amendments to Articles of Incorporation or Bylaws
31 Jan 23
DEF 14A
Definitive proxy
19 Jan 23
Latest ownership filings
SC 13G/A
LMR Partners LLP
14 Feb 23
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 23
SC 13G
Future Health ESG Associates 1, LLC
14 Feb 23
SC 13G/A
Polar Asset Management Partners Inc.
13 Feb 23
SC 13G/A
Weiss Asset Management LP
3 Feb 23
SC 13G/A
Magnetar Financial LLC
27 Jan 23
3
Initial statement of insider ownership
23 Dec 22
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 22
SC 13G
Polar Asset Management Partners Inc.
8 Feb 22
SC 13G
Weiss Asset Management LP
7 Feb 22
Financial summary
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 320.62 k | 320.62 k | 320.62 k | 320.62 k | 320.62 k | 320.62 k |
Cash burn (monthly) | 119.60 k | 53.45 k | 36.70 k | 9.60 k | 49.06 k | 130.58 k |
Cash used (since last report) | 337.33 k | 150.76 k | 103.50 k | 27.08 k | 138.36 k | 368.31 k |
Cash remaining | -16.71 k | 169.86 k | 217.12 k | 293.54 k | 182.26 k | -47.69 k |
Runway (months of cash) | -0.1 | 3.2 | 5.9 | 30.6 | 3.7 | -0.4 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 33 |
Opened positions | 6 |
Closed positions | 2 |
Increased positions | 7 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 13.83 bn |
Total shares | 11.64 mm |
Total puts | 0.00 |
Total calls | 591.88 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Future Health ESG Associates 1 | 2.63 mm | $0.00 |
LMR Partners | 1.59 mm | $3.10 bn |
Polar Asset Management Partners | 1.54 mm | $8.24 bn |
Cantor Fitzgerald, L. P. | 1.00 mm | $1.00 bn |
EHP Funds | 721.15 k | $14.46 mm |
MMCAP International Inc. SPC | 490.00 k | $9.80 mm |
TENOR CAPITAL MANAGEMENT | 489.95 k | $9.80 mm |
Citadel Advisors | 450.93 k | $9.02 mm |
Caas Capital Management | 313.44 k | $6.27 mm |
Periscope Capital | 291.64 k | $365.81 mm |